[New Developments in CKD-MBD. Why is phosphate overload harmful?]

Area of Science:

• Nephrology
• Biochemistry
• Nanomedicine

Background:

• Phosphate restriction improves outcomes in chronic kidney disease (CKD).
• The precise molecular mechanisms of phosphate toxicity in CKD are not fully understood.
• Recent research implicates calciprotein particles (CPPs) as a key mediator of phosphate-induced harm.

Purpose of the Study:

• To elucidate the role of calciprotein particles (CPPs) in the pathophysiology of chronic kidney disease (CKD).
• To investigate CPPs as potential mediators of phosphate toxicity.

Main Methods:

• Analysis of serum CPP levels in CKD patients.
• Investigation of CPPs' bioactive properties, including cell damage induction and innate immune response activation.
• Correlation of CPP levels with clinical outcomes like vascular calcification and inflammation.

Main Results:

• Serum CPP levels are elevated in CKD patients.
• CPPs are identified as colloidal nanoparticles comprising calcium phosphate crystals and proteins like Fetuin-A.
• Elevated CPPs are independently associated with vascular calcification and chronic inflammation in CKD.

Conclusions:

• Calciprotein particles (CPPs), rather than phosphate alone, may be the primary driver of phosphate toxicity in CKD.
• CPPs act as bioactive ligands inducing cellular damage and immune responses.
• CPPs play a significant role in the pathophysiology of CKD, potentially acting as a 'pathogen'.